Factors Associated With Successful Referral For Clinical Care of Drug Users With Chronic Hepatitis C Who Have or Are At Risk For HIV Infection

2004 ◽  
Vol 37 (3) ◽  
pp. 1367-1375 ◽  
Author(s):  
Dawn A Fishbein ◽  
Yungtai Lo ◽  
John F Reinus ◽  
Marc N Gourevitch ◽  
Robert S Klein
1998 ◽  
Vol 28 (6) ◽  
pp. 945-950 ◽  
Author(s):  
Stanislas Pol ◽  
Barbara Lamorthe ◽  
Ngoc Trinh Thi ◽  
Valérie Thiers ◽  
Françoise Carnot ◽  
...  

2007 ◽  
Vol 44 (4) ◽  
pp. 577-583 ◽  
Author(s):  
G. Chamie ◽  
M. Bonacini ◽  
D. R. Bangsberg ◽  
J. T. Stapleton ◽  
C. Hall ◽  
...  

AIDS ◽  
2001 ◽  
Vol 15 (15) ◽  
pp. 2011-2016 ◽  
Author(s):  
Lawrence Serfaty ◽  
Dominique Costagliola ◽  
Dominique Wendum ◽  
Odile Picard ◽  
Marie-Caroline Meyohas ◽  
...  

Author(s):  
Jeenalieva G.M. ◽  
Abdykerimova M.M. ◽  
Abdikerimov M.M.

The article presents the results of our own research on the features of the clinical course of chronic hepatitis C (HCV) in HIV-infected patients at various stages, the disease of which proceeded against the background of drug addiction. CGC was clinically characterized by the absence of vivid symptoms of hepatitis, masked not only by the symptom complex of drug addiction, but also by the concomitant pathology that determines the symptoms of HIV infection in the stage of secondary diseases. Chronic hepatitis C against the background of drug addiction is characterized by early reactivation with manifestation of hepatic and extrahepatic manifestations (asthenovegetative and dyspeptic syndromes, hepatomegaly, arthralgia), on which the symptom complex of neurological and somatic disorders inherent in drug addiction is superimposed, and is accompanied by greater activity of the liver process. It has been established that the ability of HIV infection to accelerate the natural course of HCV infection due to progressively developing immunodeficiency due to HIV.


2003 ◽  
Vol 38 ◽  
pp. 165 ◽  
Author(s):  
G. Robaeys ◽  
H. Van Vlierberghe ◽  
C. Mathei ◽  
M. Van Ranst ◽  
L. Bruckers ◽  
...  

2017 ◽  
Vol 66 (1) ◽  
pp. S416 ◽  
Author(s):  
Z. Mohamed ◽  
J. Mbwambo ◽  
J. Rwegasha ◽  
Y. Shimakawa ◽  
S. Bhagani ◽  
...  

2000 ◽  
Vol 95 (9) ◽  
pp. 2517-2517
Author(s):  
Petrea Monson ◽  
Deanna L. Oliver ◽  
Annette Pohl ◽  
Cynthia Behling ◽  
Nina Aronson ◽  
...  

2011 ◽  
Vol 48 (3) ◽  
pp. 179-185
Author(s):  
Leonora De Zorzi Piccoli ◽  
Angelo Alves de Mattos ◽  
Gabriela Perdomo Coral ◽  
Ângelo Zambam de Mattos ◽  
Diogo Edele dos Santos

CONTEXT: Chronic hepatitis C as well as non-alcoholic fatty liver disease are recognized as the main cause of liver disease in Western countries. It is common to see the concomitance of the diseases and the influence of steatosis in the sustained virological response of patients with hepatitis C virus. OBJECTIVE: Assess the sustained virological response in chronic hepatitis C patients according to the presence of liver steatosis. METHODS: One hundred sixty patients with chronic hepatitis C were retrospectively evaluated. Demographic data such as gender, age, body mass index, presence of diabetes mellitus and systemic arterial hypertension, virus genotype and use of pegylated interferon were analyzed, as was the staging of fibrosis and the presence of steatosis at histology. RESULTS: Most patients were male (57.5%), with a mean age of 48 ± 9.7 years. The most frequent genotype observed was 3 (56.9%) and, in the histological evaluation, steatosis was observed in 65% of the patients (104/160). Sustained virological response in patients with steatosis occurred in 38.5%, and in 32.1% in patients without steatosis (P = 0.54). When we analyzed possible factors associated with the presence of steatosis, only body mass index and systemic arterial hypertension revealed a significant association. When the factors that influenced sustained virological response were evaluated in a logistic regression, genotype and use of pegylated interferon proved to be independent factors associated to the response. CONCLUSION: In the evaluated patients the presence of liver steatosis did not influence the sustained virological response of patients with chronic hepatitis C treated with interferon and ribavirin.


Sign in / Sign up

Export Citation Format

Share Document